ARDELYX INC. - COMMON
6.7500
24-五月-24 14:59:58
15 分钟延时
股票
-0.6900
-9.27%
今日范围
6.6250 - 7.3600
ISIN
N/A
来源
NASDAQ
-
31 10月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
30 10月 2023 16:42:57 条件 Nasdaq GlobeNewswire
-
23 10月 2023 07:07:01 条件 Nasdaq GlobeNewswire
-
Ardelyx to Report Third Quarter 2023 Financial Results on October 31, 2023
18 10月 2023 15:02:39 条件 Nasdaq GlobeNewswire
-
17 10月 2023 18:23:38 条件 Nasdaq GlobeNewswire
-
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
17 10月 2023 18:01:06 条件 Nasdaq GlobeNewswire
-
13 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
04 10月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
28 9月 2023 07:02:00 条件 Nasdaq GlobeNewswire
-
Tenapanor for Hyperphosphatemia Approved in Japan
25 9月 2023 03:15:13 条件 Nasdaq GlobeNewswire
-
11 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 25th Annual Global Investment Conference
08 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
07 9月 2023 07:00:00 条件 Nasdaq GlobeNewswire
-
02 8月 2023 06:00:00 条件 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
27 7月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Report Second Quarter 2023 Financial Results on August 2, 2023
26 7月 2023 06:55:00 条件 Nasdaq GlobeNewswire
-
Ardelyx to Present at the H.C. Wainwright 2nd Annual Kidney Conference
20 7月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Ardelyx Announces Acceptance of New Drug Application for Tenapanor for Hyperphosphatemia in China
13 7月 2023 07:00:01 条件 Nasdaq GlobeNewswire
-
Ardelyx, Inc. Reports Employment Inducement Grants
29 6月 2023 15:09:08 条件 Nasdaq GlobeNewswire
-
05 6月 2023 07:00:01 条件 Nasdaq GlobeNewswire